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Abstract Somatostatin (SST) is a peptide hormone that ex-
erts inhibitory effects mediated through binding to specific
cell surface G protein-coupled receptors, of which five distinct
subtypes (SSTR1-SSTR5) have been characterized. Our study
performed on mouse cochlear hair cells shows the expression
and localization of the three receptors (SSTR3-SSTR5) in
wild-type (WT), single-knockout (SSTR1 KO) and double-
knockout SSTR1/SSTR2 (DKO) mice. Similar SSTRs ex-
pression were observed in the inner hair cells (IHC), outer
hair cells (OHC) and supporting cells of cultivated P7 mouse
organ of Corti (OC) explants as well as in cultivated cochlear
neuroepithelial supporting cells (NEsc). We found differences
in the expression of SSTR3-5 in WT, SSTR1 KO and DKO
mouse cochlea, which might be explained as a compensatory
effect in the cochlea after the loss of SSTR1 and/or SSTR2.
Keywords Cochlea . Hair cells . Knockout mice . Organ of
Corti . Somatostatin . Somatostatin receptor
Introduction
SST, a regulatory peptide with two bioactive forms, SST-14
and SST-28, is produced in neuroendocrine cells in the brain
and periphery and acts on a number of tissue targets to
modulate neurotransmission, cell secretion and cell prolifera-
tion (Reichlin 1983; Epelbaum et al. 1994; Patel 1999). A
family of transmembrane receptors mediates the physiological
actions of SST. Five distinct SST receptor types (SSTR1-5)
have been identified (Patel 1999).
The distribution of mRNA expression for all five SST recep-
tor types has been investigated extensively using different tech-
niques in rats and humans (Harrington et al. 1995; Kong et al.
1994; Schindler et al. 1995). Published studies are in agreement
and suggest that all SSTR types are variably expressed wide-
spread throughout the brain. In rats, SSTR1 mRNA is the most
abundant, followed by SSTR2, SSTR5, SSTR3 and SSTR4
(Patel 1999; Breder et al. 1992; Kong et al. 1994; Thoss et al.
1995; Beaudet et al. 1995). SSTR3 immunoreactivity is widely
distributed throughout the human brain and is particularly
enriched in the cortex, hippocampus, amygdala, hypothalamus
and cerebellum (Hervieu and Emson 1999; Schindler et al.
1995). Immunohistochemistry of adult rat brain sections showed
that SSTR4 is distributed in both the cell body and neuronal
processes in the cerebral cortex, hippocampus and several
nuclei of the brainstem (Selmer et al. 2000). Schreff et al.
(2000) showed that SSTR4 is strictly somatodendritic and most
likely functions in a postsynaptic manner. SSTR4 may have a
previously unappreciated function during neuronal degenera-
tion/regeneration. SSTR5 is prominently expressed in the basal
forebrain, suggesting that it is involved in the mediation of the
effects of SST on the sleep-wake cycle through its association
with cortically projecting subcortical systems (Stroh et al. 1999).
Most SSTR subtypes have been shown to modulate voltage-
gated Ca2+ channels and glutamate receptor channels in several
organ systems (Cervia and Bagnoli 2007). Excessive Ca2+
influx into cells is thought to be a major contributor to cell death
in ischemic and excitotoxic models of neuronal injury (Smaili
et al. 2009). SSTRs are also involved in the regulation of ion
channels, the inhibition of Ca2+ channels and activation of K+
channels, involved in the release of several neurotransmitters
and the modulation of neurotransmission (Patel 1999; Petrucci
et al. 2001; Johnson et al. 2001). All five subtypes of SSTRs are
expressed in themammalian retina and are distributed to specific
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cell populations, including subtypes of photoreceptor, bipolar,
amacrine and ganglion cells (Thermos 2003; Ke and Zhong
2007; Vasilaki and Thermos 2009). Studies have shown that
SST analogues may be effective therapeutic agents in retinal
diseases (Vasilaki and Thermos 2009).
However, in contrast to the situation in the retina, little
information is available on the expression or function of
somatostatin and its receptors in the inner ear. Tachibana
et al. (1979) reported on somatostatin-like immunoreactivity
in the medial geniculate body, cochlear nucleus, inferior
colliculus, auditory cortex and in the cochlea. Also,
somatostatin-like immunoreactivity could be observed in the
cochlear nuclei of postnatal rats and it was suggested that
somatostatin might be important for the development of the
auditory system (Takatsuki et al. 1982).
Our previous study demonstrated that SSTR1 and SSTR2
mRNA and protein are expressed in the mouse cochlea and
localized in IHC and OHC and in supporting cells of the OC
(Radojevic et al. 2011). The present study is the first attempt to
determine SSTR3, -4 and -5 expression in the cochlea from
WT and DKO mice.
Materials and methods
Animals
Experiments were performed on mouse cochleae from WT
C57BL/6 mice of both sexes. The patterns of SSTR3-5 ex-
pression were also observed at postnatal ages (n=10 per
postnatal day for mRNA isolation). Immunohistochemistry
was performed on four mice per postnatal day. The procedures
used to generate SSTR1−/−(homozygous SSTR1 KO)/
C57BL6J mice (Kreienkamp et al. 1999) and SSTR2−/− (ho-
mozygous SSTR2 KO)/C57BL6J mice have been described
previously (Zheng et al. 1997). SSTR1 KOmice were crossed
with SSTR2 KO mice to produce DKO mice. Age-matched
WTmice were produced fromC57BL6Jmice used to stabilize
the genetic backgrounds of SSTR1 KO and SSTR2 KO mice
(Bodmer et al. 2012).
Animal care and use were conducted in conformity with
the European Communities Council Directive of 24 Novem-
ber 1986 (86/609/EEC) and reviewed and permitted by the
Kantonales Veterinäramt, Basel, Switzerland.
Tissue extraction and culture
The mice were decapitated and cochlear microdissections
were performed under a light microscope to isolate the OC
and the spiral ganglion (SG). Brain tissue was removed from
the same animals. During microdissection, the different tis-
sues were maintained in ice-cold PBS.
RNA extraction
The SG, brain (Br) and cell lysate (Jayanthi et al. 2005) from
P7 mice, the OC from WT mouse pups (P0–P21) and OC of
DKOmouse pups by age P14 and P21 were placed separately
in RNAlater (Qiagen, Hombrechtikon, Switzerland). RNA
isolation of the brains and inner ear components was per-
formed using the RNAeasy Minikit (Qiagen) and an Ultra-
Turrax T8 tissue homogenizer (IKA-Werke, Staufen,
Germany) according to the manufacturer’s instructions, in-
cluding DNase treatment. The quantity and quality of isolated
RNAwas determined with a NanoDrop ND 1000 (NanoDrop
Technologies, DE, USA). The 260-/280-nm ratio of all sam-
ples was between 1.8 and 2.1.
Reverse transcription polymerase chain reaction
Total RNA (500 ng) was reverse transcribed into cDNA using
the first strand cDNA synthesis kit for reverse transcription
polymerase chain reaction (RT-PCR) (Roche Applied Biosci-
ence, Rotkreuz, Switzerland) according to the supplier’s in-
structions. PCR was performed using the PCR Master Mix
(Roche Applied Bioscience) with primers specific for SSTR3,
SSTR4 and SSTR5. β-actin primers were used as a positive
control for cDNA synthesis. The primers were designed to
cross at least one exon junction for the specific amplification
of cDNA and to recognize contamination with genomic DNA.
The primer sequences were:
SSTR1 forward (fwd): 5’-CAGGGTAGCCATTCTC
ATC-3’,
SSTR1 reverse (rev): 5’-AGCGTGGAAGTGACCAGA
AAG-3’,
SSTR2 (fwd): 5’-CGCATGGTGTCCATCGTAGT-3’,
SSTR2 (rev): 5’-GGATTGTGAATTGTCTGCCTTGA-3’,
SSTR3 (fwd): 5’-CTGGCTGTCAGTGGCATCTT-3’,
SSTR3 (rev): 5’-CACATGAGATCCGAAGGGC-3’,
SSTR4 fwd: 5’-CAGCGGCATGGTCACTATC-3’,
SSTR4 rev: 5’-CCGTCCACGCTAAGCACTG-3’,
SSTR5 fwd: 5’-TTCCTGGCAACGCAGAATG-3’,
SSTR5 rev: 5’-CAAGAGCGGCAGAGACATGAG-3’,
β-actin fwd, 5’-ACGGTCAGGTCATCACTATCGG
CA-3’,
β-actin rev, 5’-ATCCTGTCAGCAATGCCTGGGT-3’
(Microsynth, St. Gallen, Switzerland).
PCR reactions were performed in an Eppendorf
Mastercycler (Eppendorf, Hamburg, Germany). For SSTR3,
SSTR4 and SSTR5, an initial denaturing step at 94 °C for 30 s
was followed by 30 PCR cycles consisting in denaturation at
94 °C for 15 s, annealing at 60 °C for 30 s and extension at
72 °C for 15 s. The PCR was completed with a final extension
step at 72 °C for 3 min. β-actin was subjected to 30 PCR
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cycles consisting in denaturation at 94 °C for 30 s, annealing
at 58 °C for 45 s and extension at 72 °C for 90 s. The PCRwas
completed with a final extension step at 72° for 5 min. PCR
products were stained with SYBR Green I (Molecular Probes,
OR, USA), separated by electrophoresis on a 2 % agarose gel
and visualized under ultraviolet light. Omission of RT-PCR
was used as the no template control.
Real-time PCR
Total RNA (500 ng) was reverse transcribed into cDNA using
the First Strand cDNA synthesis kit (Roche Applied Biosci-
ences, Foster City, USA) according to the manufacturer’s
instructions. The reaction occurred in an ABI Prism 7900HT
Sequence Detection System (Applied Biosystems) using Fast
Start Universal SYBR Green Master (Rox; Roche Applied
Biosciences). The primer sequences were:
SSTR3-fwd: 5′-TGTTACCTATCCCTCATCCGAG-3′,
SSTR3-rev: 5′-GAGAGATCAAGATGCCACTGAC-3′,
SSTR4-fwd: 5′-AGCTGGGCATGGTCACTATC-3′,
SSTR4-rev: 5′-CAGACACACGAGCGCATAGA −3′
SSTR5-fwd: 5′-GGCTTCCACACCTAGCTGG-3′,
SSTR5-rev: 5′-AGCACAGGCACTAATACCGC-
3′(Microsynth).
Each reaction contained 300 nM of primer. The reaction
occurred at 95 °C for 10 min, followed by 40 cycles of 95 °C
for 15 s and 60 °C for 60 s. We calculated the relative
quantities of specifically amplified cDNA using the compar-
ative threshold cycle method. GAPDH was used as an endog-
enous reference (Microsynth) (Bodmer et al. 2012; Hall et al.
2007; Chen and Ruan 2009). Template-free and reverse
transcription-free controls excluded non-specific amplifica-
tion and DNA contamination.
Preparation of paraffin cochlear sections
The mice were killed with an overdose of sodium pentobar-
bital (100 mg/kg) and transcardially perfused with 50 ml of
phosphate-buffered 4 % paraformaldehyde (pH 7.4, 4 °C).
The inner ear was carefully removed and decalcification car-
ried out in a light-protected flask for 10 days in a solution of
Fig. 1 Immunolabeling of SST3,
-4 and -5 receptors in the mouse
cochlea at E14 and E17. SSTRs
are in red and transcription factor
Hes6 is in green (a, b, e). In the
immunofluorescence images at
E14, SSTR3, -4 and -5 can be
observed in Kölliker’s organ
(KlO), in epithelial cells located in
the embryonic cochlear duct (b, c,
d). In immunofluorescence
images at E17, SSTR4 and -5 can
be observed in the embryonic
OHC and IHC. Weak labeling
was observed in supporting cells
of the KoD. SSRT3 at age of E17
was not observed in HC.
Transcription factor Hes5 staining
was used as a marker for the
embryonic cochlea. Primary anti-
body omission was used as
negative control. Scale bar 50 μm
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120 mM EDTA (Merck, NJ, USA) in distilled water (pH 6.8).
The cochleae were then prepared for paraffin embedding by
dehydration in graded ethanol solutions (70, 80, 95 % and 3 ×
100 %, each for 1 h), xylol (3× for 1 h) and paraplast (2× at
−60 °C for 1 h and 1× at −60 °C for 10 h). The samples were
embedded in paraffin at 56 °C.
Histology and immunocytochemistry
For histological evaluation, the head of embryos and cochlear
sections were cut 8-μm-thick on a Leitz microtome andmounted
on Superfrost plus slides (Menzel, Braunschweig, Germany).
Sections were deparaffinized, rehydrated, washed in PBS for
5 min and subjected to immunohistochemistry. The NEsc at-
tached to poly-lysine-coated cover slips were fixed in 4 % para-
formaldehyde for 15 min, washed twice and kept in 0,01M PBS
at 4 °C for further processing. Microtome sections and cell
cultures were incubated for 1 h at room temperature in blocking
solution containing TBS (50mMTris, 0.9%NaCl), 0.5%Triton
X-100 (pH 7.35) and 3 % normal goat serum (NGS). The
sections were incubated with primary rabbit polyclonal anti-
SSTR3, anti-SSTR4, anti-SSTR5 (1:400; AbCam, UK), mouse
monoclonal anti-Hes5 antibody (1:300; AbCam) and mouse
monoclonal antibody against myosin VIIa (1:500; Abcam). All
antibodies were diluted in TBSwith 1%NGS overnight at 4 °C.
After three washes in TBS, the sections were incubated for 1 h at
room temperature with the appropriate Alexa-conjugated sec-
ondary antibodies (1:250; Molecular Probes, Lubio Science,
Switzerland) diluted in TBS with 1 % NGS for 2 h at room
temperature. After washing in TBS, the sections were counter-
stained with DAPI and mounted on glass slides with Mowiol.
Slices were visualized on an Olympus AX-70 microscope
equipped with a spot digital camera. The recorded images
were adjusted for brightness and contrast using Image-Pro
Plus and Photoshop image processing software.
Western blot
Animals at P21 were decapitated and cochleae were carefully
micro-dissected in ice-cold PBS. The OC was separated from
the SG and the stria vascularis (SV). Brain extract was used as a
positive control. Explants were homogenized in CelLytic buffer
containing protease inhibitor cocktail (Sigma-Aldrich, St. Lou-
is, USA) and centrifuged. Supernatants were aspirated and
placed in a new tube. Protein concentration was determined
using the BCA Protein Assay Reagent kit (Pierce, Rockford,
USA) according to the manufacturer’s instructions. Lysates
were mixed with Laemmli sample buffer and heated at 95 °C
for 5 min. Then, 20 μg of each lysate was resolved on a 10 %
SDS-PAGE gel and blotted onto a polyvinylidene fluoride
membrane. The non-specific sites of the transferred proteins
were blocked with blocking solution (Roche) diluted (1:100) in
PBS-T (1.54 mM KH2PO4; 155.17 mM NaCl; 2.71 mM
Na2HPO4-7H2O, pH 7.2; 0.1 % Tween-20) for 1 h at room
temperature. The membrane was washed with PBS-T (3 ×
10 min) and then incubated with primary antibodies in TBS.
The following primary antibodies were used: rabbit polyclonal
anti-SSTR3, anti-SSTR4 and anti-SSTR5 antibodies (1:1000;
Abcam) and mouse monoclonal anti-β-actin (1:5000, Santa
Cruz Biotech, CA, USA). The membranes were incubated with
the primary antibodies overnight at 4 °C. After that, the blots
were incubated with monoclonal anti-rabbit peroxidase-conju-
gated secondary antibody (1:80,000; Sigma-Aldrich, Switzer-
land) and anti-mouse peroxidase-conjugated secondary anti-
body (1:200,000; Sigma-Aldrich).
The blots were washed with PBS-T (3 × 10 min) and
incubated with appropriate POD-conjugated secondary anti-
body for 1 h at room temperature (Roche). After washing,
bands were visualized using developmental solution BM
Chemiluminiscence (Roche). Immunopositive bands were vi-
sualized by autoradiograpy. Serial exposures were made to
radiographic film (Hyperfilm ECL; Amersham Biosciences).
Statistical analysis and software
Statistical analyses were performed using Student’s t test for
unpaired samples. Means were considered significant when p
< 0.05. The Origin computer program (Microcal Software,
Northampton, MA, USA) was used for statistical analysis and
to generate graphs. ANOVA test was used for comparison of
multiple data, followed by the Bonferroni’s post hoc test.
Fig. 2 Expression of SSTR3, -4 and -5 in the cell lysat (Jayanthi et al.
2005) of neuroepithelial cells, SG and in OC explants at different post-
natal ages. All three mRNAs were detected in the OC of wild-type mice
using specific primer sets at P0, P5, P10, P14 and P21. Brain (Br) RNA
was used as a positive control. Omission of RT-PCR was used as the no
template control (Blatchley et al. 1987). β-actin was used to control for
cDNA synthesis. MWMMolecular weight marker
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Results
Embryonic expression of SSTR3, 4 and 5
At E14, all three SSTRs appeared to be associated with the
thickened epithelial cells located in Kölliker’s organ (Fig. 1b,
e, h). SSTR4 and SSTR5 immunoreactivity was clearly detected
at E17 in the region of hair cells and supporting cells along the
length of the cochlear duct, which in this stage have become
arranged into the characteristic patten for the OC (Fig. 1c, f, i).
Hes6 staining was used as a cochlear developmental marker and
was colocalized with SSTR5 (Fig. 1f). Primary anti body omis-
sion was used as negative control (Fig. 1a, d, g).
Expression and localization of SSTR3, -4 and -5 in the mouse
cochlea
We performed RT-PCR to determine SSTR3, -4 and -5
gene expression in the SG, CL and OC of 0-, 5-, 10-,
14- and 21-day-old WT mice. One band of the correct
size was observed for every tissue, indicating the pres-
ence of mRNA for all three SSTRs. The amplification
Fig. 3 SST3, 4 and 5 receptor
immunofluorescence labeling of
the adult mouse cochlea. a
SSTR3 (red) immunolabeling
was detected in the OC and SG. b
SSTR3 was detected in IHC,
OHC and supporting cells
Deiter’s (DC) and Pillar cells
(PC). c SSTR4 was detected in
the OC and SG. d SSTR4
immunolabeling was prominent
in the supporting cells of OHC but
was also detected in the IHC and
OHC. e SSTR5 immunolabeling
was seen in the OC and SG. f
SSTR5 was detected in IHC and
OHC. Cell nuclei (DAPI) are in
blue. Scale bars (a, c, e) 100 μm,
(b, d, f) 50 μm
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of β-actin confirmed successful cDNA synthesis and
cDNA from the brain tissue served as a positive control
(Fig. 2). Omission of RT-PCR served as a negative
control. During cochlear development, SSTR3, -4 and
-5 mRNA were not differentially expressed between
different postnatal stages.
Immunolocalization of the SST3, 4 and 5 receptor in adult
mouse cochlea
Immunohistochemistry was performed to localize SSTR3,
-4 and -5 in the adult mouse cochlea. Prominent immu-
nostaining was detected for SSTR3 in the basal part of
OHC, the apical part of IHC Pillar cells and SG cell
bodies (Fig. 3a, b). Analysis by fluorescence microscopy
revealed localization of SSTR4 in the supporting cells of
OHC. A strong signal was also detected at the apical part
of IHC (Fig. 3d). The SG exhibited a strong signal in the
cell body of ganglion cell types (Fig. 3c). SSTR5 immu-
noreactivity exhibited an overall distribution in OC with
strong immunostaining in SG cells, the apical and basal
part of OHC and the apical part of IHC (Fig. 3e, f).
SSTR3, -4 and -5 proteins expression in passaged NEsc
derived from cochlea
Immunocytochemistry was performed to localize the
three SSTRs in cultured NEsc from the immature co-
chlea. Myosin VII served as a marker for hair cells and
cell nuclei were stained in blue with DAPI. SSTR3, -4
and -5 were detected in the myosin VII-positive NEsc
and were mainly localized to the perinuclear region
(Fig. 4a–c).
SSTR3, -4 and -5 expressions in DKO cochlea
In the adult cochlea of DKO mice, the expression of
SSTR3 was restricted to IHC and OHC without positive
labeling of supporting cells Deiter’s (DC) and Pillar cells
(PC) (Fig. 5a, c) in comparison with the expression in the
cochlea of WT mice. The SSTR4 expression pattern in the
cochlea of DKO mice showed subtle differences from that
of WT mice. SSTR4 expression was detected in IHC and
OHC but it was localized to the apical part of the hair
cells compared to WT mice (Fig. 5d–f). SSTR5 protein
was prominent in the IHC and OHC of DKO cochlea. In
Fig. 4 Immunofluorescence microscopy detection of SSTR3, -4 and -5
in cultivated NEsc from the OC. Cell nuclei are depicted in blue. The cell
membranes of cultivated cells are positive for the HC marker myosin
VIIa. a Perinuclear localization of SSTR3 (red), b SSTR4 (red), and c
SSTR5 (red) were detected. Scale bar(a–c) 100 μm
722 Cell Tissue Res (2014) 358:717–727
the cochlea of KO, SSTR5 expression was observed main-
ly in the supporting cells (Fig. 5h, i).
Comparative analysis of the protein level of SSTR3, -4 and -5
in the cochlea from P7 WT and DKO mice
The expression of all three SSTRs was assessed in brain and in
OC explants fromWTand DKOmice.We observed a reduced
level of SSTR3 in DKO mice compared with WT mice
(Fig. 6). No differences in the expression of SSTR4 were
found betweenWTand DKO. The expression level of SSTR5
was higher in DKO mice than in the WT mice (Fig. 6). β-
Actin was used as loading control.
Quantitative comparison of SSTR3, -4 and -5 gene expression
in the WT and DKO mice
We performed real-time PCR to determine the quantita-
tive expression level of SSTR3, -4 and -5 in the OC of
14- and 21-day-old WT and DKO mice. The expression
of SSTR3 was significantly decreased in OC explants
from P14 mice but not from P21 mice compared to age-
matched OC explants from WT mice (Fig. 7a). The
expression of SSTR4 was significantly decreased in
the OC explants from P14 and P21 compared to the
age-matched OC explants from WT mice (Fig. 7b). The
expression of SSTR5 was increased in OC explants
from P14 and P21 DKO mice compared to age-
matched WT mice (Fig. 7c).
Discussion
We initiated this study to explore the expression of SSTR3–5
in the postnatal and adult mammalian cochlea. To learn more
about the regulation of individual SSTR receptors, we ana-
lyzed expression levels of SSTR3–5 in SSTR1 and SSRT2
receptor double-KO mice.
Fig. 5 Immunohistochemical
localization of SSTR3, 4 and 5 in
the cochlea of WT, SSTR1 KO
and DKO adult mice. Cell nuclei
are in blue. a–c SSTR3 (red)
expression in IHC and OHC in
DKO cochlea compared to WT
was reduced but high expression
was detected in the supporting
cells (DC) and (PC). No
difference was seen in expression
of SSTR3 between WT and
SSTR1 KO mice. d–f SSTR4
(red) was not differentially
expressed between WT, SSTR1
KO and DKO mice. g–i SSTR5
(red) was over expressed
prominently in the IHC as well as
supporting cells of DKO cochlea
in comparison with WT mouse
cochlea. Scale bar(a–i) 100 μm
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SSTR3 in the mouse cochlea
Using immunohistochemistry, we detected SSTR3 in
hair cells as well as in supporting cells of the OC.
Interestingly, we observed a significant down-regulation
of SSTR3 levels in SSTR1 and SSTR2 DKO mice
compared to wild-type mice. In addition, in the DKO
mice, we observed SSTR3 expression mainly in hair
cells, while in wild-type mice, SSTR3 was mainly
expressed in pillar cells. Therefore. we see an altered
expression pattern together with a decreased expression
level of SSTR3 after SSTR1 and SSTR2 deletion. What
might be the role of SSTR3 in the inner ear? To date,
we have no information on SSTR3 function within the
cochlea. Since deletion of SSTR1 and SSTR2 alters
both expression pattern and localization, we can assume
that SSTR3 has to some extent redundant functions to
SSTR1 and SSTR2. SSTR3 is also expressed in the
central nervous system. In the cortex, SSTR3 can pri-
marily be found in the layer V (Hervieu and Emson
1999). In situ studies have also confirmed those find-
ings (Kong et al. 1994; Senaris at al. 1994). It has been
speculated that SSTR3 influences cortical excitability
(Epelbaum 1986; Epelbaum et al. 1994). Finally, some
authors have suggested that SSTR3 might act as a
neurotrophic factor (Wulfsen et al. 1993; Yamada et al.
1992).
SSTR4 in the mouse cochlea
In the cochlea, we found SSTR4 expression in hair cells
and pillar cells. Most interestingly, expression of SSTR4
in hair cells was lost in SSTR1 and SSTR2 DKO mice
compared to wild-type mice. Similar to SSTR3, SSTR4
mRNA was down-regulated in DKO animals compared
to wild-type animals. Therefore, we can also assume
that SSTR4 displays to some extent redundant function
to SSTR1 and SSTR2. To date, we have no data avail-
able on the function of SSTR4 in the mammalian co-
chlea. In the brain, SSTR4 has been linked to modula-
tion of complex behaviors, including motor activity and
memory (Schreff et al. 2000). Also, SSTR4 can mediate
regional- and cell-specific postsynaptic responses
(Schreff et al. 2000; Schulz et al. 2000).
SSTR5 in the mouse cochlea
SSTR5 was found both in hair cells as well as in
supporting cells. Interestingly, in the cochlea of SSTR1
and SSTR2 DKO mice, SSTR5 was up-regulated in hair
and supporting cells. Using real-time PCR, we found an
up-regulation of SSTR5 in DKO mice compared to
wild-type mice. This finding is similar to results of
our previous studies that SSTR1 loss has a major effect
on the expression of SSTR2 (Radojevic et al. 2011).
The function of SSTR5 in the cochlea is currently not
known. In the ret ina, SSTR5 functions as an
autoreceptor and localizes to GABAergic cells, includ-
ing dopaminergic and cholinergic ACs (Ke and Zhong
2007), suggesting that the receptor is involved in pro-
tein release. The same regulation mechanism has been
found in the striatum, where it is believed that calcium
channels are involved (Akopian et al. 2000; Petrucci
et al. 2001; Sun et al. 2002; Kouvidi et al. 2006). SRIF
stimulation on SSTR5 inhibits L-type or N-type calcium
currents and activation of SSTR5 could result in
Fig. 6 Detection of SSTR3, -4 and -5 in the OC of WT and DKO mice
cochlea bywestern blotting.Western blotting reveals that SSTR3, -4 and -
5 can be detected in protein extracts fromWTand DKOOC at P21. Brain
extract from WT mice served as positive control. Actin served as a
standard to demonstrate that equal amounts of proteins have been loaded.
MWMMolecular weight marker
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increased intracellular calcium levels (Tallent et al.
1996; Sun et al. 2002; Wilkinson et al. 1997).
Regulation of SSTRs in the cochlea
No major compensatory regulation of SST or individual
SSTRs have yet been described in specific brain regions as a
consequence of the genetic deletion of SSTR1, SSTR2, or
both (Hannon et al. 2002). In contrast, major alterations of the
somatostatinergic system as a consequence of SSTR1 or
SSTR2 deletion have been demonstrated in the retina (Dal
Monte et al. 2003; Casini 2005). In retinas from SSTR KO
mice, SSTR1 and SSTR2 receptor expression have been
found to compensate for each other; SSTR1 loss resulted in
increased expression of SSTR2 (Dal Monte et al. 2003). We
found compensatory down-regulation of SSTR3 and SSTR4
and up-regulation of SSTR5 in DKO mice compared to WT
mice (Fig. 5). In SSTR1 KO mice, we observed up-regulation
of SSTR2 and SSTR5 compared to wild-type mice (Fig. 5).
Based on these observations, we can divide SSTRs into two
groups: SSTR3 and SSTR4 are down-regulated after SSTR
isoform deletion, while SSTR2 and SSTR5 are up-regulated.
To date, we do not have an answer to explain this interesting
observation. We found that all five SSTR subtypes were
Fig. 7 The cochlear gene
expression of SSTR3, 4 and 5 in
OC explants at P14 and P21 from
WT and DKO mice. The relative
distribution of SSTR3, -4 and -5
mRNA expression in OC tissue
from WT and DKO mice of
different postnatal ages was
quantified by real-time PCR.
GAPDH was used as an
endogenous control. Gene
expression levels are expressed as
the mean (±SE) fold increase
compared to the values obtained
in OC explants from P14 and P21
WT and DKO mice. Data were
obtained from five independent
experiments. *p < 0.002,
**p < 0.004 using Student’s t test
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expressed in the cochlea with considerable regional overlap
(Fig. 8). The function of these five receptors in the OC is
currently unknown.
Conclusion
In summary, the present study is the first to describe the
expression of SSTR3-5 in cochlear tissue. Together with our
previous study (Radojevic et al. 2011), we demonstrated that
all five SST receptors are compartmentally expressed in the
OC and SG. The presence of SSTRs within the mammalian
cochlea, their specific expression in the OC and their
subtypespecific compensatory regulation as a consequence
of distinct SSTR deletion suggest an important role of the
somatostatinergic system within the inner ear. These receptors
may have crucial functional roles in the inner ear and dys-
function of these receptors may lead to hearing disturbances
(Bodmer et al. 2012).
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